Development and proof of principle of new clinical applications of theranostics solutions

This section outlines the types of entities eligible to receive funding, the geographical reach of the program, and its core objectives in advancing theranostics solutions. The program targets a wide range of organizations across the European Union and associated countries, with a clear focus on improving patient care and strengthening European healthcare capabilities through innovative theranostic applications.

This section details the types of projects and activities eligible for funding, focusing on innovative multi-modal theranostic solutions. Supported projects will address unmet public health needs and advance these technologies from development to early-phase clinical trials, along with efforts to improve manufacturing and training.

This section provides details on the financial support offered, including the type of instrument, the maximum funding available per project, and specific financial requirements for industry contribution.

This section outlines the essential conditions and requirements for participation, covering admissibility, eligibility, financial capacity, consortium structure, and specific provisions including intellectual property rights.

This section details the steps involved in submitting a proposal and how the evaluation and selection processes are conducted.

This section identifies the foundational legal and policy documents that govern the program, ensuring transparency and adherence to European frameworks.